United States · FDA National Drug Code directory

DNA Insulin Drops 2019

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 63083-2019_91ade3ff-25ab-464b-8084-9fb5d5d6d955
Product NDC: 63083-2019
Form: LIQUID
Composition / generic term: DNA Insulin Drops
Labeler: Professional Complementary Health Formulas
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start / end (source format): 19840815
Source listing expiry: 20271231

Source-listed ingredients

CHROMIUM — 6 [hp_X]/59mL
LYCOPODIUM CLAVATUM SPORE — 6 [hp_X]/59mL
VANADIUM — 6 [hp_X]/59mL
PANCRELIPASE AMYLASE — 6 [hp_X]/59mL
INSULIN GLULISINE — 12 [hp_X]/59mL
PHOSPHORIC ACID — 30 [hp_X]/59mL
URANYL NITRATE HEXAHYDRATE — 30 [hp_X]/59mL
RADIUM BROMIDE — 60 [hp_X]/59mL

These values do not establish equivalence or a dose recommendation.

Packages

59 mL in 1 BOTTLE, DROPPER (63083-2019-2) · 63083-2019-2

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →